Vinay Prasad, child murderer
By 
The editorial board at the World Socialist Review Wall Street Journal centers the RFK Jr. henchman responsible for destroying many potential life-saving innovations for literally no reason whatsoever than the medieval superstitions he shares with the asshole who appointed him:
It’s hard to recall a regulator who has done as much damage to medical innovation in as little time as Vinay Prasad. In his latest drive-by shooting, the leader of the Food and Drug Administration’s vaccine division rejected Moderna’s mRNA flu vaccine without even a cursory review. This is arbitrary government at its worst.
The FDA rarely refuses to review a drug or vaccine application. Our sources say the FDA has rejected only about 4% of applications without a review, typically when they are missing important information. That wasn’t the case with Moderna.
Dr. Prasad spiked Moderna’s flu vaccine because its Phase 3 trial was putatively not “adequate and well-controlled.” He quibbled that the control group in Moderna’s late-stage trial didn’t receive the “best-available standard of care.” He decides what is “best.”
Moderna launched a global randomized controlled trial in September 2024 with 41,000 participants, half of whom received its vaccine. The other half received a standard flu vaccine as a control. The FDA blessed its trial design, and agency staffers gave Moderna a thumbs up to apply for approval last August based on the results. Its vaccine was 27% more effective at preventing symptomatic cases of flu and 49% more effective against hospitalization than the standard flu vaccine.
Yet Dr. Prasad said Moderna should have used a high-dose flu vaccine as its control rather than a standard dose—though that wasn’t possible. In the U.S., high-dose flu vaccines are typically given only to seniors over age 65. They aren’t available in many European countries where Moderna conducted its trial. That’s in part because government-run health systems don’t want to pay for expensive high-dose vaccines. Irony alert: Dr. Prasad is a fan of single-payer healthcare.
Even so, Moderna’s vaccine proved equally effective as high-dose shots in a side-by-side comparison with a standard dose. One advantage of Moderna’s mRNA vaccines, however, is that they can be quickly adapted and manufactured to match new strains.
Remember: every member of the Republican Senate conference save one voted for this. Eugenicists each and every one.